|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research & Development | |||||
| Selling, general and administrative | |||||
| Depreciation | |||||
| Goodwill impairment | |||||
| Amortization | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expenses): | |||||
| Interest expense | |||||
| Other (expenses) income | |||||
| Total other (expenses) income | |||||
| Net (Loss) Income Before Income Taxes | |||||
| Provision for Income Taxes | |||||
| Current | |||||
| Total (Provision) Benefit for Income Taxes | |||||
| Net Income (Loss) before discontinued Operations | |||||
| Income (Loss) from Discontinued Operations, net of taxes | |||||
| Net Loss | |||||
| Less: Dividends attributable to non-common stockholders’ of OMNIQ Corp | |||||
| Net loss attributable to common stockholders’ of OMNIQ Corp | |||||
| Net loss per share- basic | |||||
| Net loss per share- diluted | |||||
| Net (loss) per share for continuing operations | |||||
| Net income (loss) per share for discontinued operations | |||||
| Weighted average number of common shares outstanding- basic | |||||
| Weighted average number of common shares outstanding- diluted | |||||
| Net Income (Loss) | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
Loading...